Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.

Radhia M’kacher(Genopole (France)), C Parmentier, A Gaussen, D. Violot(Institut Gustave Roussy), Nadine Béron‐Gaillard(Institut Gustave Roussy), Martin Schlumberger(Université Paris-Saclay), Jean-Denis Légal

PubMed

May 1, 1998

Cited by 38

Related Papers

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

|PubMed|2001|287

<i>SDHB</i> mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

|International Journal of Cancer|2014|207

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

|The Journal of Clinical Endocrinology & Metabolism|2013|119

Current Concepts in the Management of Unilateral Recurrent Laryngeal Nerve Paralysis after Thyroid Surgery

|The Journal of Clinical Endocrinology & Metabolism|2005|113

A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with <i>RET</i>-altered cancers.

|Journal of Clinical Oncology|2018|104